Periodic Reporting for period 1 - HypoSkin (Unique breakthrough ex vivo human skin model to predict efficacy and toxicity of subcutaneous drugs)

Drug administration by subcutaneous injection is highly increasing during the past years (average CAGR of 7% between 2014 and 2018). However, low predictability of currents animal models used in preclinical tests leads to 88% of drug attrition during clinical trial causing a...